| 1 | Ca-A Cancer Journal for Clinicians | 649.8 | 99th | Q1 | SCIE | – | No |
| 2 | Journal of Hematology and Oncology | 70.1 | 99th | Q1 | SCIE | – | Yes |
| 3 | Annals of Oncology | 69.6 | 98th | Q1 | SCIE | – | No |
| 4 | Journal of the National Cancer Center | 31.2 | 97th | Q1 | ESCI | – | Yes |
| 5 | The Lancet Haematology | 29.4 | 97th | Q1 | SCIE | – | No |
| 6 | Blood | 22.8 | 96th | Q1 | SCIE | – | No |
| 7 | Experimental Hematology and Oncology | 19.6 | 95th | Q1 | SCIE | – | Yes |
| 8 | Leukemia | 19.2 | 95th | Q1 | SCIE | – | No |
| 9 | Blood Cancer Journal | 16.2 | 94th | Q1 | SCIE | – | Yes |
| 10 | American Journal of Hematology | 14.9 | 93rd | Q1 | SCIE | – | No |
| 11 | Blood Cancer Discovery | 13.9 | 93rd | Q1 | ESCI | – | No |
| 12 | Blood Reviews | 12.7 | 92nd | Q1 | SCIE | – | No |
| 13 | Blood Advances | 11.8 | 91st | Q1 | SCIE | – | Yes |
| 14 | Thrombosis and Haemostasis | 11 | 91st | Q1 | SCIE | – | No |
| 15 | Haematologica | 9.7 | 90th | Q1 | SCIE | – | Yes |
| 16 | Critical Reviews in Oncology/Hematology | 9.5 | 89th | Q1 | SCIE | – | No |
| 17 | Radiotherapy and Oncology | 9.1 | 89th | Q1 | SCIE | – | No |
| 18 | Journal of Thrombosis and Haemostasis | 8.8 | 88th | Q1 | SCIE | – | No |
| 19 | Seminars in Thrombosis and Hemostasis | 8.8 | 87th | Q1 | SCIE | – | No |
| 20 | Transplantation and Cellular Therapy | 8.1 | 87th | Q1 | SCIE | – | No |
| 21 | Journal of Clinical Laboratory Analysis | 8.1 | 86th | Q1 | SCIE | – | Yes |
| 22 | Bone Marrow Transplantation | 7.6 | 85th | Q1 | SCIE | – | No |
| 23 | Seminars in Hematology | 7.5 | 85th | Q1 | SCIE | – | No |
| 24 | Cytokine | 7.2 | 84th | Q1 | SCIE | – | No |
| 25 | HemaSphere | 6.9 | 83rd | Q1 | SCIE | – | Yes |
| 26 | British Journal of Haematology | 6.6 | 83rd | Q1 | SCIE | – | No |
| 27 | Platelets | 6.6 | 82nd | Q1 | SCIE | – | Yes |
| 28 | Current Hematologic Malignancy Reports | 6.6 | 81st | Q1 | SCIE | – | No |
| 29 | Medical Oncology | 5.9 | 81st | Q1 | SCIE | – | No |
| 30 | Thrombosis Research | 5.8 | 80th | Q1 | SCIE | – | No |
| 31 | Current Opinion in HIV and AIDS | 5.8 | 79th | Q1 | SCIE | – | No |
| 32 | Hematology/Oncology Clinics of North America | 5.7 | 79th | Q1 | SCIE | – | No |
| 33 | Current Research in Translational Medicine | 5.5 | 78th | Q1 | SCIE | – | No |
| 34 | Current Opinion in Hematology | 5.4 | 77th | Q1 | SCIE | – | No |
| 35 | Transfusion Medicine Reviews | 5.3 | 77th | Q1 | SCIE | – | No |
| 36 | Therapeutic Advances in Hematology | 5.3 | 76th | Q1 | SCIE | – | Yes |
| 37 | Hematological Oncology | 5.2 | 75th | Q1 | SCIE | – | No |
| 38 | Vascular Health and Risk Management | 5.2 | 75th | Q1 | ESCI | – | Yes |
| 39 | Hematology (United States) | 5.1 | 74th | Q2 | SCIE | – | No |
| 40 | Journal of Thrombosis and Thrombolysis | 4.9 | 73rd | Q2 | SCIE | – | No |
| 41 | Seminars in Oncology | 4.9 | 73rd | Q2 | SCIE | – | No |
| 42 | Blood Research | 4.9 | 72nd | Q2 | ESCI | – | Yes |
| 43 | Blood Transfusion | 4.8 | 71st | Q2 | SCIE | – | No |
| 44 | International Journal of Clinical Oncology | 4.8 | 71st | Q2 | SCIE | – | No |
| 45 | Research and Practice in Thrombosis and Haemostasis | 4.7 | 70th | Q2 | SCIE | – | Yes |
| 46 | Immunobiology | 4.7 | 69th | Q2 | SCIE | – | Yes |
| 47 | Blood Purification | 4.6 | 69th | Q2 | SCIE | – | No |
| 48 | Transfusion Medicine and Hemotherapy | 4.6 | 68th | Q2 | SCIE | – | Yes |
| 49 | European Journal of Haematology | 4.5 | 67th | Q2 | SCIE | – | No |
| 50 | Haemophilia | 4.4 | 67th | Q2 | SCIE | – | No |
| 51 | Journal of Blood Medicine | 4.4 | 66th | Q2 | ESCI | – | Yes |
| 52 | Cancer Control | 4.3 | 65th | Q2 | SCIE | – | Yes |
| 53 | Hematology/ Oncology and Stem Cell Therapy | 4.2 | 65th | Q2 | – | – | Yes |
| 54 | Blood Science | 4.2 | 64th | Q2 | ESCI | – | Yes |
| 55 | Clinical Hemorheology and Microcirculation | 4.1 | 63rd | Q2 | SCIE | – | No |
| 56 | Expert Review of Hematology | 4.1 | 63rd | Q2 | SCIE | – | No |
| 57 | Journal of Clinical Apheresis | 4.1 | 62nd | Q2 | SCIE | – | No |
| 58 | Leukemia Research | 4.1 | 61st | Q2 | SCIE | – | No |
| 59 | Stem Cells and Development | 4 | 61st | Q2 | SCIE | – | No |
| 60 | Experimental Hematology | 4 | 60th | Q2 | SCIE | – | No |
| 61 | Acta Oncologica | 3.9 | 59th | Q2 | SCIE | – | Yes |
| 62 | Pediatric Blood and Cancer | 3.9 | 59th | Q2 | SCIE | – | No |
| 63 | Leukemia and Lymphoma | 3.9 | 58th | Q2 | SCIE | – | No |
| 64 | Clinical and Applied Thrombosis/Hemostasis | 3.8 | 57th | Q2 | SCIE | – | Yes |
| 65 | Hamostaseologie | 3.8 | 57th | Q2 | SCIE | – | No |
| 66 | Thrombosis Journal | 3.8 | 56th | Q2 | SCIE | – | Yes |
| 67 | Blood Cells, Molecules, and Diseases | 3.7 | 55th | Q2 | SCIE | – | No |
| 68 | International Journal of Laboratory Hematology | 3.6 | 55th | Q2 | SCIE | – | No |
| 69 | Kidney and Dialysis | 3.5 | 54th | Q2 | ESCI | – | Yes |
| 70 | Clinical Hematology International | 3.4 | 53rd | Q2 | – | – | Yes |
| 71 | International Journal of Hematology | 3.4 | 53rd | Q2 | SCIE | – | No |
| 72 | Anemia | 3.3 | 52nd | Q2 | ESCI | – | Yes |
| 73 | Annals of Hematology | 3.3 | 51st | Q2 | SCIE | – | Yes |
| 74 | Hematology (United Kingdom) | 3.2 | 51st | Q2 | SCIE | – | Yes |
| 75 | Mediterranean Journal of Hematology and Infectious Diseases | 3.2 | 50th | Q2 | SCIE | – | Yes |
| 76 | Transfusion | 3.2 | 50th | Q2 | SCIE | – | No |
| 77 | Vox Sanguinis | 3.2 | 49th | Q3 | SCIE | – | No |
| 78 | Therapeutic Apheresis and Dialysis | 3 | 48th | Q3 | SCIE | – | No |
| 79 | Current Medicinal Chemistry: Cardiovascular and Hematological Agents | 2.9 | 48th | Q3 | – | – | No |
| 80 | Acta Haematologica | 2.9 | 47th | Q3 | SCIE | – | No |
| 81 | Turkish Journal of Hematology | 2.7 | 46th | Q3 | SCIE | – | Yes |
| 82 | Annals of Blood | 2.6 | 46th | Q3 | ESCI | – | No |
| 83 | Clinical Lymphoma, Myeloma and Leukemia | 2.6 | 45th | Q3 | SCIE | – | No |
| 84 | Oncology Research and Treatment | 2.4 | 44th | Q3 | SCIE | – | No |
| 85 | Transfusion Medicine | 2.3 | 44th | Q3 | SCIE | – | No |
| 86 | Pediatric Hematology and Oncology | 2.3 | 43rd | Q3 | SCIE | – | No |
| 87 | Blood Coagulation and Fibrinolysis | 2.3 | 42nd | Q3 | SCIE | – | No |
| 88 | Hematology Reports | 2.3 | 42nd | Q3 | ESCI | – | Yes |
| 89 | Hematology, Transfusion and Cell Therapy | 2.2 | 41st | Q3 | ESCI | – | Yes |
| 90 | EJC Paediatric Oncology | 2.2 | 40th | Q3 | ESCI | – | Yes |
| 91 | Hemodialysis International | 2.2 | 40th | Q3 | SCIE | – | No |
| 92 | Transfusion Clinique et Biologique | 2.2 | 39th | Q3 | SCIE | – | No |
| 93 | Journal of Clinical and Experimental Hematopathology | 2.2 | 38th | Q3 | ESCI | – | Yes |
| 94 | Thrombosis Update | 2.2 | 38th | Q3 | – | – | Yes |
| 95 | Transfusion and Apheresis Science | 2.1 | 37th | Q3 | SCIE | – | No |
| 96 | Flebologiya | 2 | 36th | Q3 | – | – | No |
| 97 | Hemato | 1.9 | 36th | Q3 | ESCI | – | Yes |
| 98 | Journal of Pediatric Hematology/Oncology | 1.8 | 35th | Q3 | SCIE | – | No |
| 99 | Cardiovascular and Hematological Disorders - Drug Targets | 1.8 | 34th | Q3 | – | – | No |
| 100 | Hemoglobin | 1.8 | 34th | Q3 | SCIE | – | No |
| 101 | Lymphology | 1.7 | 33rd | Q3 | SCIE | – | No |
| 102 | Annals of Clinical and Laboratory Science | 1.7 | 32nd | Q3 | SCIE | – | No |
| 103 | Advances in Hematology | 1.6 | 32nd | Q3 | – | – | Yes |
| 104 | Bulletin du Cancer | 1.6 | 31st | Q3 | SCIE | – | No |
| 105 | Leukemia Research Reports | 1.6 | 30th | Q3 | ESCI | – | Yes |
| 106 | Immunopathologia Persa | 1.5 | 30th | Q3 | ESCI | – | No |
| 107 | Iranian Journal of Blood and Cancer | 1.5 | 29th | Q3 | – | – | Yes |
| 108 | Clinical Advances in Hematology and Oncology | 1.3 | 28th | Q3 | ESCI | – | No |
| 109 | Indian Journal of Hematology and Blood Transfusion | 1.3 | 27th | Q3 | SCIE | – | No |
| 110 | Frontiers in Hematology | 1.2 | 26th | Q3 | ESCI | – | Yes |
| 111 | Memo - Magazine of European Medical Oncology | 1.2 | 26th | Q3 | ESCI | – | No |
| 112 | Acta Haematologica Polonica | 1.2 | 25th | Q3 | ESCI | – | Yes |
| 113 | Immunohematology | 1.1 | 24th | Q4 | – | – | No |
| 114 | Pediatric Hematology Oncology Journal | 1.1 | 24th | Q4 | – | – | Yes |
| 115 | Blood Neoplasia | 1.1 | 23rd | Q4 | – | – | Yes |
| 116 | Gematologiya i Transfuziologiya | 1 | 22nd | Q4 | SCIE | – | No |
| 117 | International Journal of Hematology-Oncology and Stem Cell Research | 1 | 22nd | Q4 | – | – | Yes |
| 118 | Asian Journal of Transfusion Science | 0.9 | 21st | Q4 | ESCI | – | Yes |
| 119 | Chinese Journal of Hematology | 0.9 | 20th | Q4 | – | – | No |
| 120 | Iranian Journal of Pediatric Hematology and Oncology | 0.8 | 20th | Q4 | ESCI | – | No |
| 121 | Healthbook TIMES Oncology Hematology | 0.8 | 19th | Q4 | – | – | Yes |
| 122 | Journal of Haemophilia Practice | 0.7 | 18th | Q4 | – | – | No |
| 123 | Journal of Hematopathology | 0.7 | 18th | Q4 | SCIE | – | No |
| 124 | Blood Vessels, Thrombosis and Hemostasis | 0.7 | 17th | Q4 | – | – | Yes |
| 125 | Klinicheskaya Onkogematologiya/Clinical Oncohematology | 0.7 | 16th | Q4 | – | – | Yes |
| 126 | Pediatric Hematology/Oncology and Immunopathology | 0.7 | 16th | Q4 | – | – | No |
| 127 | Oncogematologiya | 0.6 | 15th | Q4 | – | – | No |
| 128 | Bleeding, Thrombosis and Vascular Biology | 0.6 | 14th | Q4 | ESCI | – | Yes |
| 129 | European Oncology and Haematology | 0.6 | 14th | Q4 | – | – | No |
| 130 | Veins and Lymphatics | 0.6 | 13th | Q4 | – | – | Yes |
| 131 | Annals of Thoracic Surgery Short Reports | 0.5 | 12th | Q4 | – | – | Yes |
| 132 | Tromboz, Gemostaz i Reologiya | 0.5 | 12th | Q4 | – | – | No |
| 133 | Iraqi Journal of Hematology | 0.5 | 11th | Q4 | ESCI | – | Yes |
| 134 | Chinese Journal of Blood Transfusion | 0.5 | 10th | Q4 | – | – | Yes |
| 135 | Journal of Applied Hematology | 0.5 | 10th | Q4 | – | – | Yes |
| 136 | Russian Journal of Pediatric Hematology and Oncology | 0.4 | 9th | Q4 | – | – | No |
| 137 | Hematology in Clinical Practice | 0.4 | 8th | Q4 | – | – | No |
| 138 | Journal of Lymphoedema | 0.4 | 8th | Q4 | – | – | No |
| 139 | Onkologie | 0.3 | 7th | Q4 | SCIE | – | No |
| 140 | Journal of Clinical Hematology | 0.3 | 6th | Q4 | – | – | No |
| 141 | Journal of Sickle Cell Disease | 0.3 | 6th | Q4 | – | – | Yes |
| 142 | Archive of Oncology | 0.3 | 5th | Q4 | – | – | Yes |
| 143 | Transfuze a Hematologie Dnes | 0.2 | 4th | Q4 | – | – | No |
| 144 | UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi | 0.2 | 4th | Q4 | SCIE | – | No |
| 145 | Revista Cubana de Hematologia, Inmunologia y Hemoterapia | 0.2 | 3rd | Q4 | – | – | Yes |
| 146 | Hematology (Bulgaria) | 0.1 | 2nd | Q4 | – | – | No |
| 147 | Journal of Leukemia and Lymphoma | 0.1 | 2nd | Q4 | – | – | No |
| 148 | Hematology Transfusiology Eastern Europe | 0 | 1st | Q4 | – | – | No |
| 149 | Journal of B.U.ON. | 0 | 0th | Q4 | – | – | No |
| 150 | Sang Thrombose Vaisseaux | 0 | 0th | Q4 | – | – | No |